Royalties in Tech Transfer Alliances
Executive Summary
In Vivo reviews recent royalty rates in tech transfer-to-biotech licensing deals.
You may also be interested in...
University Deal Valuations
How do the financial terms of deals signed with university tech transfer offices differ when the licensor is a biotech, compared to a Big Pharma? We broke out university deals signed by these kinds of licensors to find out.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.